Project details
- Project period
- 1 May 2025 - 30 Apr 2029
- Total cost
- €5 164 865,00
- Global Health EDCTP3 funding
- €5 164 865,00
- Call identifier
- HORIZON_HORIZON-JU-GH-EDCTP3-2024-01-01-two-stage
- Status
- In progress
- Project type
- Research and Innovation Actions (RIA)
- Disease area
- HIV/AIDS
- Intervention type
- Therapies
Consortium map
Coordinator
UNIVERSITE DE BORDEAUX
- Location
- BORDEAUX, France
- EU contribution
- €1 132 755,00
- Total cost
- €1 538 255,00
Scientific project leader
INSTITUT DE RECHERCHES MEDICALES ET D'ETUDES DES PLANTES MEDICINALES
Location: Yaounde, Cameroon
Beneficiaries
THE UNIVERSITY OF SHEFFIELD
- Location
- SHEFFIELD, United Kingdom
- EU contribution
- €359 883,75
- Total cost
- €359 883,75
Instituto Nacional de Saúde
- Location
- Marracuene, Mozambique
- EU contribution
- €962 648,75
- Total cost
- €962 648,75
ASSOCIATION PAC-CI
- Location
- ABIDJAN, Côte d’Ivoire
- EU contribution
- €884 705,00
- Total cost
- €884 705,00
INSTITUT DE RECHERCHES MEDICALES ET D'ETUDES DES PLANTES MEDICINALES
- Location
- Yaounde, Cameroon
- EU contribution
- €1 041 168,75
- Total cost
- €1 041 168,75
INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT
- Location
- Marseille, France
- EU contribution
- €378 203,75
- Total cost
- €378 203,75
Partners
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Location
- PARIS, France
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
- Location
- Paris, France
Faculty of Associated Medical Sciences, Chiang Mai University
- Location
- Chiang Mai, Thailand
FUNDACAO OSWALDO CRUZ
- Location
- Rio De Janeiro, Brazil
Related projects
Eliminating post-natal transmission of HIV to infantsThe PROMISE-ZERO project is assessing the wider roll-out of a strategy for reducing mother-to-child transmission of HIV, with the...
Supporting women living with HIV after pregnancyThe DOLPHIN-3 project is assessing whether it is feasible to temporarily transfer women living with HIV from oral antiretroviral therapy (ART)...
Once-weekly pills for HIV controlThe POA project is evaluating a radically simplified HIV treatment regimen that could make it much easier for people living with HIV to control viral...